2025 Education Manufacturing Provider 
Alabama Academy of Family Physicians
MAY 15, 2025
The 2025 Alabama Legislative Session concluded on May 14 at midnight. What Happened: The Senate Committee on Finance and Taxation Education did not meet to discuss the bill. This bill would provide a civil action for pharmacists, pharmacies, and insurance beneficiaries for injuries due to violations by a pharmacy benefits manager.
Minnesota Academy of Family Physicians
MARCH 27, 2025
As we move into the tenth week of the legislative session, Minnesota Academy of Family Physicians (MAFP) lobbyist Megan Verdeja breaks down what’s happening at the Minnesota State Capitol and provides an update on health care bills. SENATE EDUCATION POLICY COMMITTEE S.F. Highlights follow. Read a summary of S.F.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Physician's Weekly
JUNE 18, 2025
Cost-sharing and education may improve access to GLP-1 therapies for obesity, but systemic barriers remain, requiring broader policy and clinical reforms. Healthcare Professionals Among healthcare professionals, potential barriers include lack of education, safety concerns, and obesity stigma/weight bias.
My Green Doctor
MAY 3, 2025
The breadth of services provided by modern day medicine is profound. Organizations such as EyeSustain and My Green Doctor are educating clinicians and practice managers on ways to reduce medical waste and are promoting research on this topic. The product manufacturers and vendors will need to be active partners as well.
FDA Law Blog
SEPTEMBER 22, 2024
Instead, we focus here on the few notable statements that provide new or more detailed guidance than FDA has previously offered. MDR FDA discussed a few preliminary steps that it says laboratories should take prepare for submitting MDRs as medical device manufacturers. By Steven J. Gonzalez & Lisa M.
Alabama Academy of Family Physicians
FEBRUARY 19, 2025
As the 2025 legislative session swings into full gear, the Alabama Academy of Family Physicians (AAFP) has set its sights on a cadre of pivotal bills set to shape the healthcare landscape for years to come. Any contractual clause that limits or penalizes providers for sharing this information would be unenforceable.
FDA Law Blog
JULY 7, 2024
Laboratories struggling to understand the myriad implications of being regulated as device “manufacturers” were hopeful that additional guidance would shed light on how to apply FDA’s existing medical device regulatory framework to their operations. 803), Reporting of Corrections and Removals (21 C.F.R. § 806) and Complaint Files (21 C.F.R.
Expert insights. Personalized for you.
130 
Let's personalize your content